NCT02508155View on ClinicalTrials.gov

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

PHASE1CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

November 17, 2015

Primary Completion Date

December 23, 2020

Study Completion Date

December 23, 2020

Conditions
Chronic Pain
Interventions
BIOLOGICAL

MEDI7352 for IV infusion

MEDI7352 for IV infusion

BIOLOGICAL

Placebo for IV infusion

IV Placebo infusion

BIOLOGICAL

MEDI7352 for Subcutaneous Injection

MEDI7352 for subcutaneous injection

BIOLOGICAL

Placebo for Subcutaneous Injection

Subcutaneous Placebo Injection

Trial Locations (6)

10117

Research Site, Berlin

413 45

Research Site, Göteborg

141 86

Research Site, Stockholm

BT2 7BA

Research Site, Belfast

NW10 7EW

Research Site, London

M13 9NQ

Research Site, Manchester

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY